Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance

Clinical trial NCT02467010 · COMPLETED

Trial details

NCT number: NCT02467010
Sponsor: University Medical Center Groningen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2008-09-01
Primary completion: 2013-07-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.